Effects of inhibiting Na+/H+-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling

Cardiovascular Research

Volumn 54, Issue 2, 2002, Pages 438-446

  Shinagawa, Kaori ^a   Mitamura, Hideo ^b   Ogawa, Satoshi ^b   Nattel, Stanley ^a,c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b KEIO UNIVERSITY   (Japan)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Antiarrhythmic agents; Arrhythmia (mechanisms); ECG; Ion exchangers; Renin angiotensin system

Indexed keywords

CARIPORIDE; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; SODIUM PROTON EXCHANGE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVERSION; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG EFFECT; HEART ATRIUM FIBRILLATION; NONHUMAN; PRIORITY JOURNAL; REFRACTORY PERIOD; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT OUTCOME;

ACTION POTENTIALS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; DOGS; ENALAPRIL; GUANIDINES; MODELS, ANIMAL; SODIUM-HYDROGEN ANTIPORTER; SULFONES; TIME FACTORS;

EID: 0036219401     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(01)00515-6     Document Type: Article

References (45)

1. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats
2. Chronic rapid atrial pacing: Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation
3. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: Roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation
4. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model
5. Pacing-induced chronic atrial fibrillation impairs sinus node function in dogs: Electrophysiological remodeling
6. Intracellular calcium changes and tachycardia-induced contractile dysfunction in canine atrial myocytes
7. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans
8. Tachycardia-induced change of atrial refractory period in humans: Rate dependency and effects of antiarrhythmic drugs
9. Electrical remodeling in atrial fibrillation. Time course and mechanisms
10. 2+ channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs
11. Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs
12. Effect of verapamil on long-term tachycardia-induced atrial electrical remodeling
13. + exchanger in short-term atrial electrophysiological remodeling
14. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation
15. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat
16. Chronic atrial fibrillation from rapid atrial pacing is associated with reduced atrial blood flow: A positron emission tomography study
17. + exchange during ischaemia and reperfusion of normal and diabetic rat hearts
18. + antiporter inhibitor on postischemic reperfusion in pig heart
19. + exchange inhibitor and its effects in cardiac ischaemia
20. Na-H exchange in myocardium: Effects of hypoxia and acidification on Na and Ca
21. Amiloride delays the ischemia-induced rise in cytosolic free calcium
22. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction
23. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation
24. Signal transduction underlying arrhythmogenic atrial remodeling due to congestive heart failure
25. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort
26. The mathematical formulation of the problem of conduction of impulses in a network of connected excitable elements, specifically in cardiac muscle
27. Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644
28. Verapamil reduces tachycardia-induced electrical remodeling of the atria
29. Atrial electrophysiological remodeling caused by rapid atrial activation: Underlying mechanisms and clinical relevance to atrial fibrillation
30. Increased expression of extracellular signal-regulated kinase and angiotensin converting enzyme in human atria during atrial fibrillation
31. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans
32. Effects of angiotensin converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure
33. + exchange: Structure, regulation, and its role in heart disease
34. + exchange inhibition reduces hypertrophy and heart failure after myocardial infarction in rats
35. Successful ventricular defibrillation by the selective sodium-hydrogen exchanger isoform-1 inhibitor cariporide
36. + exchanger delays the development of rapid pacing-induced atrial contractile dysfunction
37. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial
38. Ionic mechanisms underlying human atrial action potential properties: Insights from a mathematical model
39. Mathematical analysis of canine atrial action potentials: Rate, regional factors and electrical remodeling
40. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation
41. Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation
42. 2+ channel in persistent atrial fibrillation in humans
43. Ion channel remodeling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation
44. Flecainide reduces tachycardia-induced electrical remodeling of the atria
45. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation